## HPV Types and CIN Risk Stratification **Key Point:** HPV-16 is the most common high-risk HPV type associated with CIN and cervical cancer, accounting for approximately 50–60% of all cervical cancers and a significant proportion of CIN lesions. ### HPV Classification by Oncogenic Potential | HPV Type | Risk Category | Association with CIN/Cancer | Prevalence in Lesions | |----------|---------------|----------------------------|----------------------| | HPV-16 | High-risk | Most common in CIN-2/3 and invasive cancer | 50–60% of cancers | | HPV-18 | High-risk | Associated with adenocarcinoma | 15–20% of cancers | | HPV-31, 33, 45 | High-risk | Less common than HPV-16/18 | 5–10% combined | | HPV-6, 11 | Low-risk | Benign warts, minimal CIN risk | <1% of cancers | **High-Yield:** HPV-16 and HPV-18 together account for ~70% of cervical cancers. HPV-16 is the single most oncogenic type and the strongest predictor of progression from CIN-1 to CIN-3. ### Clinical Significance **Clinical Pearl:** In a woman with ASCUS and positive HPV, HPV-16 positivity carries the highest risk of underlying CIN-2/3 or cancer and warrants immediate colposcopy and biopsy, whereas HPV-18 and other high-risk types also require colposcopy but may have slightly lower immediate progression risk. **Mnemonic:** **HR-HPV (High-Risk)** = 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68. Of these, **HPV-16 is #1** in frequency and oncogenic potential. **Warning:** Do not confuse HPV-6 and HPV-11 (low-risk types causing benign genital warts) with high-risk types. These are NOT associated with CIN progression. [cite:Park 26e Ch 3]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.